Encora Therapeutics Device for Essential Tremor Receives FDA Clearance

Encora Therapeutics, an MIT spinoff, has secured FDA clearance for its device designed to assist adults with essential tremor. The technology, initially developed from an MIT product-design class project, marks a notable achievement in translating academic innovation into practical medical solutions. This clearance offers a new treatment option for individuals managing neurological conditions.